Respiratory syncytial virus, ok subject to pregnancy vaccine

The doubts expressed by some experts about the safety of a new vaccine against respiratory syncytial virus in pregnancy should reassure the rigor of controls, not the other way around.

After authorizing the respiratory syncytial virus vaccine for the over 60s, the US Food and Drug Administration (FDA) will have to decide whether to give the green light to the one that protects newborns through future mothers.